151 related articles for article (PubMed ID: 37586917)
1. SOHO State of the Art Updates and Next Questions | Treatment of Richter's Transformation.
Romano I; Condoluci A; Rossi D
Clin Lymphoma Myeloma Leuk; 2023 Nov; 23(11):786-799. PubMed ID: 37586917
[TBL] [Abstract][Full Text] [Related]
2. Richter's Transformation.
Sigmund AM; Kittai AS
Curr Oncol Rep; 2022 Aug; 24(8):1081-1090. PubMed ID: 35384590
[TBL] [Abstract][Full Text] [Related]
3. Accelerated Chronic Lymphocytic Leukemia and Richter Transformation in the Era of Novel Agents.
Levy Yurkovski I; Tadmor T
Acta Haematol; 2024; 147(1):73-83. PubMed ID: 37666234
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Richter's Transformation with Novel Therapies.
Bajwa A; Habib A; Kittai AS
Curr Hematol Malig Rep; 2024 Apr; 19(2):45-55. PubMed ID: 38194201
[TBL] [Abstract][Full Text] [Related]
5. Coexistence of chronic myeloid leukemia and diffuse large B-cell lymphoma with antecedent chronic lymphocytic leukemia: a case report and review of the literature.
Abuelgasim KA; Rehan H; Alsubaie M; Al Atwi N; Al Balwi M; Alshieban S; Almughairi A
J Med Case Rep; 2018 Mar; 12(1):64. PubMed ID: 29524963
[TBL] [Abstract][Full Text] [Related]
6. Richter's transformation in chronic lymphocytic leukemia.
Jain P; O'Brien S
Oncology (Williston Park); 2012 Dec; 26(12):1146-52. PubMed ID: 23413591
[TBL] [Abstract][Full Text] [Related]
7. Are we closer to a standard of care for Richter's syndrome? Novel treatments on the horizon.
Pham N; Coombs CC; O'Brien S
Expert Rev Hematol; 2024; 17(4-5):117-126. PubMed ID: 38693662
[TBL] [Abstract][Full Text] [Related]
8. Cellular Therapy Advances in Chronic Lymphocytic Leukemia and Richter's Syndrome.
Bajwa A; Voorhees TJ; Kittai AS
Curr Probl Cancer; 2022 Feb; 46(1):100827. PubMed ID: 34991902
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of Richter's transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database.
Elnair R; Ellithi M; Kallam A; Shostrom V; Bociek RG
Ann Hematol; 2021 Oct; 100(10):2513-2519. PubMed ID: 34279675
[TBL] [Abstract][Full Text] [Related]
10. Emerging Therapies for the Management of Richter Transformation.
Smyth E; Eyre TA; Cheah CY
J Clin Oncol; 2023 Jan; 41(2):395-409. PubMed ID: 36130148
[TBL] [Abstract][Full Text] [Related]
11. Novel Approaches for the Treatment of Patients with Richter's Syndrome.
Iannello A; Deaglio S; Vaisitti T
Curr Treat Options Oncol; 2022 Apr; 23(4):526-542. PubMed ID: 35294723
[TBL] [Abstract][Full Text] [Related]
12. Richter's transformation: Transforming the clinical landscape.
Barrett A; Appleby N; Dreau H; Fox CP; Munir T; Eyre TA
Blood Rev; 2024 Mar; 64():101163. PubMed ID: 38097488
[TBL] [Abstract][Full Text] [Related]
13. Detection of Richter's transformation of chronic lymphocytic leukemia by PET/CT.
Bruzzi JF; Macapinlac H; Tsimberidou AM; Truong MT; Keating MJ; Marom EM; Munden RF
J Nucl Med; 2006 Aug; 47(8):1267-73. PubMed ID: 16883004
[TBL] [Abstract][Full Text] [Related]
14. Haematological cancer: Richter's transformation in CLL-a distinct lymphoma.
Jain P; Young KH
Nat Rev Clin Oncol; 2014 Jan; 11(1):6-8. PubMed ID: 24281057
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus infection in Richter's transformation.
Ansell SM; Li CY; Lloyd RV; Phyliky RL
Am J Hematol; 1999 Feb; 60(2):99-104. PubMed ID: 9929100
[TBL] [Abstract][Full Text] [Related]
16. Richter's Transformation in the Era of Kinase Inhibitor Therapy: A Review.
Ayers EC; Mato AR
Clin Lymphoma Myeloma Leuk; 2017 Jan; 17(1):1-6. PubMed ID: 27707629
[TBL] [Abstract][Full Text] [Related]
17. Richter's syndrome: biology and therapy.
Yee KW; O'Brien SM; Giles FJ
Cancer J; 2005; 11(3):161-74. PubMed ID: 16053658
[TBL] [Abstract][Full Text] [Related]
18. Richter's transformation in patients with chronic lymphocytic leukaemia: a Nationwide Epidemiological Study.
Ben-Dali Y; Hleuhel MH; da Cunha-Bang C; Brieghel C; Poulsen CB; Clasen-Linde E; Bentzen HHN; Frederiksen H; Christiansen I; Nielsen LH; Enggaard L; Helleberg M; Clausen M; Frederiksen M; Pedersen RS; Niemann CU; Andersen MA
Leuk Lymphoma; 2020 Jun; 61(6):1435-1444. PubMed ID: 32031030
[TBL] [Abstract][Full Text] [Related]
19. Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study.
Younes A; Brody J; Carpio C; Lopez-Guillermo A; Ben-Yehuda D; Ferhanoglu B; Nagler A; Ozcan M; Avivi I; Bosch F; Caballero Barrigón MD; Hellmann A; Kuss B; Ma DDF; Demirkan F; Yağci M; Horowitz NA; Marlton P; Cordoba R; Wrobel T; Buglio D; Streit M; Hodkinson BP; Schaffer M; Alvarez J; Ceulemans R; Balasubramanian S; de Jong J; Wang SS; Fourneau N; Jurczak W
Lancet Haematol; 2019 Feb; 6(2):e67-e78. PubMed ID: 30642819
[TBL] [Abstract][Full Text] [Related]
20. Practical Management of Richter Transformation in 2023 and Beyond.
Ryan CE; Davids MS
Am Soc Clin Oncol Educ Book; 2023 Jan; 43():e390804. PubMed ID: 37141545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]